Bispecific antibodies in the treatment of multiple myeloma - Top-Institutions - MDSpire

Bispecific antibodies in the treatment of multiple myeloma

  • By

  • Anup Joseph Devasia

  • Ajai Chari

  • Guido Lancman

  • September 12, 2024

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology
    • Oncology
    • Immunotherapy

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Oncology
    • Immunotherapy

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology
    • Oncology
    • Immunotherapy

  • #4

    University of Texas MD Anderson Cancer Center
    University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology
    • Oncology
    • Immunotherapy

  • #5

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology
    • Oncology
    • Immunotherapy

Original Source(s)

Bispecific antibodies in the treatment of multiple myeloma

  • by Anup Joseph Devasia, Ajai Chari, Guido Lancman

  • September 12, 2024

Related Content

Editorial: A new perspective on the importance of dendritic cells in cancer immunity: from bench to patient’s bedside

Prognostic Impact of Early Disease Progression and Early Mortality in Patients with Multiple Myeloma: A Real-World Cohort Study

Cutaneous adverse events following CAR T-cell therapy in hematologic malignancies